首页 | 本学科首页   官方微博 | 高级检索  
     


Management of Gastrointestinal Stromal Tumors
Affiliation:1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1484, Houston, TX 77030, USA;2. Department of Surgery, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA;3. Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA;1. Taussig Cancer Institute, Department of Hematology and Oncology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA;2. Digestive Disease Institute, Department of Colorectal Surgery, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA;3. Digestive Disease Institute, HPB and Liver Transplant Program, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA;1. Neuroendocrine Tumor Unit, Department of Endocrinology, Hadassah-Hebrew University Medical Center, P.O.B. 12000, Jerusalem 91120, Israel;2. 1st Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Mikras Asias 75, Athens 11527, Greece;3. Department of Pathophysiology, National and Kapodistrian University of Athens, Mikras Asias 75, Athens 11527, Greece;1. Division of Gastroenterology U, San Giovanni AS University-Teaching Hospital, Via Cavour 31, Torino 10123, Italy;2. Gastroenterology Unit, Valduce Hospital, Via Dante 11, Como 22100, Italy;3. The Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK;1. Department of Internal Medicine, 6431 Fannin Street, MSB 1.150, Houston, TX 77030, USA;2. Division of Gastroenterology, Hepatology, and Nutrition, 6431 Fannin Street, MSB 4.234, Houston, TX 77030, USA
Abstract:
Keywords:Gastrointestinal stromal tumor  GIST  Gastric mass  Abdominal tumor  Tyrosine kinase inhibitor  TKIs  Imatinib  Sunitinib
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号